These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30908282)

  • 1. What's New in Intra-Arterial Chemotherapy for Retinoblastoma?
    Abramson DH; Francis JH; Gobin YP
    Int Ophthalmol Clin; 2019; 59(2):87-94. PubMed ID: 30908282
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
    Manjandavida FP; Stathopoulos C; Zhang J; Honavar SG; Shields CL
    Indian J Ophthalmol; 2019 Jun; 67(6):740-754. PubMed ID: 31124482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosurgery for retinoblastoma: what we know after 5 years.
    Abramson DH
    Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221
    [No Abstract]   [Full Text] [Related]  

  • 4. Retinoblastoma therapy delivers power of chemotherapy with surgical precision.
    Friedrich MJ
    JAMA; 2011 Jun; 305(22):2276-8. PubMed ID: 21642669
    [No Abstract]   [Full Text] [Related]  

  • 5. Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications.
    Radros J; All-Eriksson C; Pal N; Holm S; Seregard S; Söderman M; Arnberg F; Holmin S
    Acta Ophthalmol; 2018 Dec; 96(8):e1040-e1041. PubMed ID: 29687588
    [No Abstract]   [Full Text] [Related]  

  • 6. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture.
    Abramson DH
    Br J Ophthalmol; 2010 Apr; 94(4):396-9. PubMed ID: 20424209
    [No Abstract]   [Full Text] [Related]  

  • 7. [The key points in intravenous chemotherapy and intra-arterial chemotherapy on retinoblastoma treatment].
    Zhao JY; Zhang CY
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):566-569. PubMed ID: 28851195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma.
    Santapuram PR; Schremp EA; Friedman DL; Koyama T; Froehler MT; Daniels AB
    Ophthalmol Retina; 2021 Mar; 5(3):309-312. PubMed ID: 32920208
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.
    Abramson DH; Marr BP; Dunkel IJ; Brodie S; Zabor EC; Driscoll SJ; Gobin YP
    Br J Ophthalmol; 2012 Apr; 96(4):499-502. PubMed ID: 22053101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N; Català-Mora J
    J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY; Medina CA; Aziz HA; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma.
    Qureshi AM; Davies LK; Patel PA; Rennie A; Robertson F
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):713-717. PubMed ID: 30872423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of intra-arterial chemotherapy for retinoblastoma.
    Monroy JE; Orbach DB; VanderVeen D
    Semin Ophthalmol; 2014; 29(5-6):429-33. PubMed ID: 25325870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superselective intraophthalmic artery chemotherapy: what we do not know.
    Wilson MW; Haik BG; Dyer MA
    Arch Ophthalmol; 2011 Nov; 129(11):1490-1. PubMed ID: 22084220
    [No Abstract]   [Full Text] [Related]  

  • 16. Intra-arterial and oral digoxin therapy for retinoblastoma.
    Patel M; Paulus YM; Gobin YP; Djaballah H; Marr B; Dunkel IJ; Brodie S; Antczak C; Folberg R; Abramson DH
    Ophthalmic Genet; 2011 Sep; 32(3):147-50. PubMed ID: 21446853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma.
    Wyse E; Handa JT; Friedman AD; Pearl MS
    Pediatr Radiol; 2016 Aug; 46(9):1223-33. PubMed ID: 26886915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-Up.
    Bertelli E; Leonini S; Galimberti D; Moretti S; Tinturini R; Hadjistilianou T; De Francesco S; Romano DG; Vallone IM; Cioni S; Gennari P; Galluzzi P; Grazzini I; Rossi S; Bracco S
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1289-95. PubMed ID: 26915566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for Malignant Intraocular Tumors.
    Shah CP; Shields CL; Shields JA
    Dev Ophthalmol; 2016; 55():337-43. PubMed ID: 26501748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Chemotherapeutic Agents for the Treatment of Retinoblastoma Using the Intra-Arterial and Intravitreal Routes: A Path Forward Toward Drug Discovery.
    Yuan S; Friedman DL; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):129-141. PubMed ID: 27898619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.